DE69332820D1 - Impfstoff gegen den hepatitis e-virus und verfahren - Google Patents
Impfstoff gegen den hepatitis e-virus und verfahrenInfo
- Publication number
- DE69332820D1 DE69332820D1 DE69332820T DE69332820T DE69332820D1 DE 69332820 D1 DE69332820 D1 DE 69332820D1 DE 69332820 T DE69332820 T DE 69332820T DE 69332820 T DE69332820 T DE 69332820T DE 69332820 D1 DE69332820 D1 DE 69332820D1
- Authority
- DE
- Germany
- Prior art keywords
- hev
- virus
- effective
- antibody
- infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000724675 Hepatitis E virus Species 0.000 title abstract 6
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 108090000565 Capsid Proteins Proteins 0.000 abstract 1
- 102100023321 Ceruloplasmin Human genes 0.000 abstract 1
- 108700026244 Open Reading Frames Proteins 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 210000003494 hepatocyte Anatomy 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/28011—Hepeviridae
- C12N2770/28022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/28011—Hepeviridae
- C12N2770/28111—Hepevirus, e.g. hepatitis E virus
- C12N2770/28122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82233592A | 1992-01-17 | 1992-01-17 | |
US07/870,985 US6455492B1 (en) | 1988-06-17 | 1992-04-20 | Hepatitis E virus vaccine and method |
PCT/US1993/000475 WO1993014208A2 (en) | 1992-01-17 | 1993-01-19 | Hepatitis e virus vaccine and method |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69332820D1 true DE69332820D1 (de) | 2003-05-08 |
DE69332820T2 DE69332820T2 (de) | 2004-01-29 |
Family
ID=27124631
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69332820T Expired - Lifetime DE69332820T2 (de) | 1992-01-17 | 1993-01-15 | Impfstoff gegen den hepatitis e-virus und verfahren |
Country Status (9)
Country | Link |
---|---|
US (3) | US6455492B1 (de) |
EP (1) | EP0623169B1 (de) |
JP (2) | JP3746291B2 (de) |
AT (1) | ATE236255T1 (de) |
CA (1) | CA2125701A1 (de) |
DE (1) | DE69332820T2 (de) |
DK (1) | DK0623169T3 (de) |
ES (1) | ES2196008T3 (de) |
WO (1) | WO1993014208A2 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6214970B1 (en) | 1988-06-17 | 2001-04-10 | Genelabs Technologies, Inc. | Hepatitis E virus antigens and uses therefor |
US5789559A (en) * | 1988-06-17 | 1998-08-04 | Genelabs Technologies, Inc. | DNA sequences of enterically transmitted non-A/non-B hepatitis viral agent |
US5686239A (en) * | 1988-06-17 | 1997-11-11 | Genelabs Technologies, Inc. | Hepatitis E virus peptides and methods |
US6291641B1 (en) | 1988-06-17 | 2001-09-18 | Genelabs Technologies, Inc. | Hepatitis E virus antigens and uses therefor |
US6455492B1 (en) * | 1988-06-17 | 2002-09-24 | Genelabs Technologies, Inc. | Hepatitis E virus vaccine and method |
US6787145B1 (en) | 1992-09-18 | 2004-09-07 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
US6207416B1 (en) | 1992-09-18 | 2001-03-27 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
ATE449178T1 (de) * | 1992-09-18 | 2009-12-15 | Us Gov Health & Human Serv | Rekombinante proteine eines pakistani stammes von hepatitis e-virus sowie ihre verwendung in diagnostischen verfahren und als vakzine |
US5736315A (en) * | 1992-10-21 | 1998-04-07 | National Institute Of Health | Methods and compositions for detecting anti-hepatitis E virus activity |
US5563032A (en) * | 1992-10-21 | 1996-10-08 | The United States Of America As Represented By The Department Of Health And Human Services | Mosaic polypeptide and methods for detecting the hepatitis E virus |
CA2170521A1 (en) * | 1993-09-24 | 1995-03-30 | David Andrew Anderson | Immunoreactive antigens of hepatitis e virus |
US5830636A (en) * | 1993-12-22 | 1998-11-03 | Abbott Laboratories | HEV orf-2 monoclonal antibodies and methods for using same |
EP0736088A1 (de) * | 1993-12-22 | 1996-10-09 | Abbott Laboratories | Monoklonale antikörper gegen das hepatitis-e-virus und verfahren für ihre verwendung |
WO1995017501A1 (en) * | 1993-12-22 | 1995-06-29 | Abbott Laboratories | Monoclonal antibodies against hev orf-2 and methods for using same |
US6054567A (en) * | 1997-04-11 | 2000-04-25 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
US6458562B1 (en) | 1998-04-09 | 2002-10-01 | The United States Of America As Represented By The Secretary Of Health And Human Services | Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
CA2283538A1 (en) * | 1999-09-30 | 2001-03-30 | Mun Hon Ng | New hev antigenic peptide and methods |
US7005130B2 (en) * | 2001-01-05 | 2006-02-28 | Virginia Tech Intellectual Properties, Inc. | Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E |
US20030220475A1 (en) * | 2001-04-03 | 2003-11-27 | Fields Howard A. | Neutralizing immunogenic hev polypepetides |
US6614586B2 (en) * | 2001-07-30 | 2003-09-02 | Dorsal Networks, Inc. | Methods and systems for high performance, wide bandwidth optical communication systems using Raman amplification |
US7309589B2 (en) * | 2004-08-20 | 2007-12-18 | Vironix Llc | Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing |
RU2501568C1 (ru) * | 2012-04-27 | 2013-12-20 | Закрытое акционерное общество научно-производственная компания "Комбиотех" | Рекомбинантная вакцина для профилактики вирусного гепатита е у животных |
RU2493249C1 (ru) * | 2012-04-27 | 2013-09-20 | Закрытое акционерное общество научно-производственная компания "Комбиотех" | Рекомбинантный штамм дрожжей hansenula polymorpha - продуцент капсидного белка вируса гепатита е |
RU2501809C1 (ru) * | 2012-04-27 | 2013-12-20 | Закрытое акционерное общество научно-производственная компания "Комбиотех" | Способ получения рекомбинантного капсидного белка вируса гепатита е и рекомбинантная вакцина для профилактики вирусного гепатита е |
WO2020011752A1 (en) * | 2018-07-10 | 2020-01-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Antibodies having specificity for the orf2i protein of hepatitis e virus and uses thereof for diagnostic purposes |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5218099A (en) * | 1986-04-01 | 1993-06-08 | The United States Of America As Represented By The Department Of Health And Human Services | Post-transfusion, non-A, non-B hepatitis virus polynucleotides |
FR2597606B1 (fr) * | 1986-04-16 | 1989-10-06 | Pasteur Institut | Nouveau reactif pour la detection d'hepatites virales non a non b et procede de diagnostic de telles hepatites par voie immunoenzymatique |
US5741490A (en) * | 1988-06-17 | 1998-04-21 | Genelabs Technologies, Inc. | Hepatitis E virus vaccine and method |
WO1989012641A1 (en) * | 1988-06-17 | 1989-12-28 | Genelabs Incorporated | Enterically transmitted non-a/non-b hepatitis viral agent |
US5686239A (en) * | 1988-06-17 | 1997-11-11 | Genelabs Technologies, Inc. | Hepatitis E virus peptides and methods |
US6455492B1 (en) * | 1988-06-17 | 2002-09-24 | Genelabs Technologies, Inc. | Hepatitis E virus vaccine and method |
US5885768A (en) * | 1988-06-17 | 1999-03-23 | The United States Of America As Represented By The Department Of Health And Human Services | Hepatitis E virus peptide antigen and antibodies |
US5202430A (en) * | 1990-01-16 | 1993-04-13 | University Of Tennessee | Transmissible gastroenteritis virus genes |
JPH04506608A (ja) * | 1990-04-05 | 1992-11-19 | ジェネラブス テクノロジイズ,インコーポレイティド | 腸内伝達された非―a/非―b肝炎ウイルス物質及びその特徴的なエピトープ |
JPH04200388A (ja) * | 1990-11-29 | 1992-07-21 | Chemo Sero Therapeut Res Inst | 流行性非a非b型肝炎ウイルス抗原ペプチドおよびこれをコードする核酸断片 |
ATE449178T1 (de) * | 1992-09-18 | 2009-12-15 | Us Gov Health & Human Serv | Rekombinante proteine eines pakistani stammes von hepatitis e-virus sowie ihre verwendung in diagnostischen verfahren und als vakzine |
-
1992
- 1992-04-20 US US07/870,985 patent/US6455492B1/en not_active Expired - Fee Related
-
1993
- 1993-01-15 DK DK93911555T patent/DK0623169T3/da active
- 1993-01-15 ES ES93911555T patent/ES2196008T3/es not_active Expired - Lifetime
- 1993-01-15 EP EP93911555A patent/EP0623169B1/de not_active Expired - Lifetime
- 1993-01-15 CA CA002125701A patent/CA2125701A1/en not_active Abandoned
- 1993-01-15 DE DE69332820T patent/DE69332820T2/de not_active Expired - Lifetime
- 1993-01-15 AT AT93911555T patent/ATE236255T1/de not_active IP Right Cessation
- 1993-01-19 JP JP51271493A patent/JP3746291B2/ja not_active Expired - Fee Related
- 1993-01-19 WO PCT/US1993/000475 patent/WO1993014208A2/en active IP Right Grant
-
1995
- 1995-06-07 US US08/484,054 patent/US5770689A/en not_active Expired - Lifetime
-
2002
- 2002-06-06 US US10/165,868 patent/US20030143241A1/en not_active Abandoned
-
2005
- 2005-10-19 JP JP2005305068A patent/JP2006036795A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
ATE236255T1 (de) | 2003-04-15 |
WO1993014208A3 (en) | 1993-10-14 |
JP2006036795A (ja) | 2006-02-09 |
EP0623169A1 (de) | 1994-11-09 |
DK0623169T3 (da) | 2003-07-21 |
EP0623169B1 (de) | 2003-04-02 |
US20030143241A1 (en) | 2003-07-31 |
US5770689A (en) | 1998-06-23 |
JP3746291B2 (ja) | 2006-02-15 |
US6455492B1 (en) | 2002-09-24 |
WO1993014208A2 (en) | 1993-07-22 |
JPH08509201A (ja) | 1996-10-01 |
CA2125701A1 (en) | 1993-07-22 |
DE69332820T2 (de) | 2004-01-29 |
ES2196008T3 (es) | 2003-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69332820D1 (de) | Impfstoff gegen den hepatitis e-virus und verfahren | |
LU91393I2 (fr) | "La combinaison de la protéine L1 recombinante du papillomavirus humain de types 16 et 18" - Cervarix | |
PT101052A (pt) | Proteinas hibridas uteis na preparacao de vacinas | |
ATE125821T1 (de) | Vakzin gegen hepatitis b. | |
LU91323I2 (fr) | Vaccin papillomavirus humain Ätypes 6,11,16,18Ü(recombinant, adsorbé).-silgard | |
DE60043708D1 (de) | Verfahren zur erhaltung zellimmuneantworten gegen proteinen | |
ATE295895T1 (de) | Genetischer impfstoff gegen den immunschwäche virus | |
ATE449178T1 (de) | Rekombinante proteine eines pakistani stammes von hepatitis e-virus sowie ihre verwendung in diagnostischen verfahren und als vakzine | |
DE60039715D1 (de) | Hcv-impfstoff zusammensetzungen | |
MX9603182A (es) | Vacuna de hepatitis b. | |
NO971529D0 (no) | Rekombinante proteiner av en Pakistani stamme av hepatitt E og deres anvendelse i diagnostiske metoder og vaksiner | |
KR920002629A (ko) | B형 간염 코어 항원의 아미노산 잔기 서열 | |
FI923020A (fi) | Inte a inte b-sekvenser. | |
YU45292A (sh) | Različiti površinski proteini hepatitis b virusa koji obrazuju čestice | |
ATE111488T1 (de) | Rekombiniebares hepatitis-delta-antigen, verfahren zu seiner reinigung und verwendung. | |
RU93043621A (ru) | Способы получения гликопротеинов нсv, способ очистки, аналитический набор, способ выявления нсv, способ элиминации нсv, способ индукции иммунитета, гликопротеины, иммунореагенты | |
DE69331796D1 (de) | Kernantigenprotein des Hepatitis C-Virus, sowie diagnostisches Verfahren und Satz von Reagenzen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |